Return on Equity: The amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Calculated as: Income from Continuing Operations / Total Common Equity
Decoy Therapeutics Inc (DCOY) had Return on Equity of -57.37% for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
-- |
|
$-2.22M |
|
-- |
|
-- |
|
$2.28M |
|
$-2.28M |
|
$0.06M |
|
$-2.22M |
|
$-2.22M |
|
$-2.22M |
|
$-2.22M |
|
$-2.22M |
|
$-2.22M |
|
$-2.28M |
|
$-2.28M |
|
0.53M |
|
0.53M |
|
$-4.18 |
|
$-4.18 |
|
| Balance Sheet Financials | |
$8.36M |
|
$0.04M |
|
$0.07M |
|
$8.42M |
|
$4.55M |
|
-- |
|
-- |
|
$4.55M |
|
$3.88M |
|
$3.88M |
|
$3.88M |
|
0.53M |
|
| Cash Flow Statement Financials | |
$-2.89M |
|
-- |
|
-- |
|
$10.71M |
|
$7.82M |
|
$-2.89M |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.84 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-2.89M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
|
Return on Equity |
-57.37% |
-57.37% |
|
-26.41% |
|
-57.37% |
|
$7.29 |
|
$-5.43 |
|
$-5.43 |
|